about
Primary biliary cirrhosis in the era of liver transplantationGeographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.Anti-HLA and anti-MICA antibodies in liver transplant recipients: effect on long-term graft survival.Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?Structure of Post-Transplant Care in a Single Transplant Center.Pulmonary post-transplant lymphoproliferative disorder with a CT halo sign.Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis.Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report.Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection.Total homocysteine as a risk factor for vascular disease in renal transplant recipients.Recurrence of primary sclerosing cholangitis in patients after liver transplantation.36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.Effect of immunosuppressive regimen on acute rejection and liver graft function.Acute liver transplant rejection: incidence and the role of high-doses steroids.Cytomegalovirus infection as a common complication following liver transplantation.Anti-CD25 and tacrolimus therapy may not prevent early primary biliary cirrhosis recurrence after liver transplantation: two case reports.Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index.Efficacy of rapamycin in patient with juvenile rheumatoid arthritis.Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.Pregnancy outcomes among female recipients after liver transplantation: further experience.Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.How to choose a statin after kidney transplantation: case analyses.Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery.Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years' observation.Relapsing polychondritis in a liver transplant recipient: A case report.1000 liver transplantations at the Department of General, Transplant and Liver Surgery, Medical University of Warsaw--analysis of indications and results.Weight gain in renal transplant recipients in a Polish single centre.Oxidative Stress in Kidney Diseases: The Cause or the Consequence?The impact of experience of a transplantation center on the outcomes of orthotopic liver transplantation.Effects of liver transplantation on health-related quality of life in patients with primary biliary cholangitis (PBC)[The role of T helper lymphocytes population: Th1, Th2, and Th3 in human immune response]Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in miceInfluence of angiotensin-converting enzyme inhibitor treatment of the carotid artery intima-media complex in renal allograft recipientsAntioxidant potential in renal allograft recipients with stable graft functionUrine cytokines profile in renal transplant patients with asymptomatic bacteriuriaThe effects of indomethacin on angiogenic factors mRNA expression in renal cortex of healthy ratsTonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative diseaseProteolytic enzymes activities in patients after myocardial infarction correlate with serum concentration of TGF-beta
P50
Q27005784-B8B925E8-8ED8-49CD-9514-18529FA93B4DQ34318250-63AF7573-2CD7-4FFE-AAAF-E1F2E7F9CDC6Q34422205-7C80AF83-0FD4-482E-9C89-F45BDD62F4FFQ36241388-3945BBC6-45A5-40AF-A57F-6FAD1C542EF4Q37380304-8A5D13A6-8748-462C-91FE-772B24930A63Q37767556-CFA2CB26-82E6-477C-BE6A-EF8BF6E21187Q39863324-7CA860B2-2A31-450B-A587-BB77AAFF710AQ40234327-9DF6BD4E-E40E-4A43-BB19-A1E55E16128DQ42197257-E83D6B26-D35B-47A1-A872-7347BBC736B6Q42239909-48050A4B-4635-4996-B30F-807EEB00C996Q43450040-BB88016B-364B-4F29-A063-FEF2EC14001DQ43992381-344C6136-5A3D-4940-B53D-6DF3B81D2BC3Q44539448-8551276A-3109-4D22-AAF9-A1C31F6C9712Q44608598-CF9DE614-350B-4038-B5E1-1B47E2E9A8DDQ44608653-4C910D27-CBCB-45F4-8CC9-E21C6F85BE8AQ44608661-246C6796-5604-4E09-B569-9A30D295610AQ44608668-40918340-9FA0-4960-A7BB-FB3E25ACC2E8Q44608678-21459195-983A-4576-A82A-D554FB657455Q45217775-410D085C-E949-44E3-9B40-C935F1CF61AAQ45282294-C51A947D-4E12-44C9-9B01-0F19B79ECB4DQ46071971-D0201863-7FE8-4F92-9CF3-F0B91AD6201EQ46574787-54C01205-2C76-4481-9A12-54C003CECF30Q46965987-FEA62643-E585-4836-849A-502BBD8FF2FEQ46966042-6565F742-0C6B-438F-867B-80A80ACE11C9Q46966048-03BADD16-9C14-4D7F-84E2-E3257899918CQ46966068-4C1524C8-EC51-48DC-A845-7E5B511F2AFBQ47110300-EEBD8677-F9F9-4750-895C-6EB659A19570Q47329019-FE9CAFE3-DD06-41A7-8E0C-4B26AA5DB9BFQ47414006-2155FB2E-6935-4EC0-B665-05A30A76DC2DQ48163520-B0747ECD-2437-4D4C-BC11-89EEC85EF2C7Q52099456-5C14017A-8689-418B-99EA-DACE0183B7D1Q58605472-35F9BB4B-C871-4A50-8BCE-200DC2B1AB1DQ73034615-2523F1D3-4AA5-422A-8AC3-EDD3BB0878A7Q73593284-E289522C-C995-4F2C-B868-32B5FCEC731DQ74339717-9268F60A-CFE8-4E33-AFBB-800F6C675F3AQ74339750-CD3DF98F-7C7B-4BE0-A315-3785543805AAQ79775597-D7C09B60-0EBA-4A9E-B718-EEEA4F2E8FCBQ80171996-DF7A591D-3FE5-4E92-9037-4876B64786A8Q80407832-B15A3ABA-3F73-4F09-99A5-2C46B721C10EQ81142781-D96CC529-20D7-4C4A-B773-9B9A619A7E3B
P50
description
Pools onderzoeker
@nl
cercetător polonez
@ro
chercheur polonais
@fr
hulumtues
@sq
investigador polaco
@es
investigador polaco
@gl
investigador polacu
@ast
investigador polonès
@ca
polnischer Forscher
@de
polski naukowiec
@pl
name
Krzysztof Mucha
@ast
Krzysztof Mucha
@ca
Krzysztof Mucha
@de
Krzysztof Mucha
@en
Krzysztof Mucha
@es
Krzysztof Mucha
@fr
Krzysztof Mucha
@ga
Krzysztof Mucha
@gl
Krzysztof Mucha
@it
Krzysztof Mucha
@nl
type
label
Krzysztof Mucha
@ast
Krzysztof Mucha
@ca
Krzysztof Mucha
@de
Krzysztof Mucha
@en
Krzysztof Mucha
@es
Krzysztof Mucha
@fr
Krzysztof Mucha
@ga
Krzysztof Mucha
@gl
Krzysztof Mucha
@it
Krzysztof Mucha
@nl
prefLabel
Krzysztof Mucha
@ast
Krzysztof Mucha
@ca
Krzysztof Mucha
@de
Krzysztof Mucha
@en
Krzysztof Mucha
@es
Krzysztof Mucha
@fr
Krzysztof Mucha
@ga
Krzysztof Mucha
@gl
Krzysztof Mucha
@it
Krzysztof Mucha
@nl
P214
P106
P108
P1153
6701759234
P1412
P1559
Krzysztof Mucha
@pl
P21
P213
0000 0001 1383 7836
P214
P27
P31
P496
0000-0002-6613-7638
P734
P735
P7859
viaf-166424443